March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

PDL to dissolve by year-end
PDL BioPharma Inc. (NASDAQ:PDLI) said it will cease operations and seek to sell the company or monetize its assets. PDL acquires commercial-stage pharmaceutical assets and late clinical stage products. On Monday, the company said VP, Chief Accounting Officer and acting CFO

Read the full 454 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers